# CardioMEMS European Monitoring Study for Heart Failure

Study · id `cardio:ct-nct02693691` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02693691](<https://clinicaltrials.gov/study/NCT02693691>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02693691

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 239 participants.

## Technical summary

Registry record NCT02693691. Allocation not applicable; no masking; primary purpose treatment. Start 2016-05 (registry gives no type); primary completion 2019-03-31 (actual). Results posted on 2020-08-14.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 239 participants (enrolled count; ClinicalTrials.gov record NCT02693691, source copy `cardio:ctgov-nct02693691-2022-04-05`, retrieved 2026-10-26)
- Start date: 2016-05 (registry gives no type) (ClinicalTrials.gov record NCT02693691, source copy `cardio:ctgov-nct02693691-2022-04-05`, retrieved 2026-10-26)
- Primary completion: 2019-03-31 (actual) (ClinicalTrials.gov record NCT02693691, source copy `cardio:ctgov-nct02693691-2022-04-05`, retrieved 2026-10-26)
- Completion: 2020-03-01 (actual) (ClinicalTrials.gov record NCT02693691, source copy `cardio:ctgov-nct02693691-2022-04-05`, retrieved 2026-10-26)
- Results first posted: 2020-08-14 (ClinicalTrials.gov record NCT02693691, source copy `cardio:ctgov-nct02693691-2022-04-05`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT02693691, source copy `cardio:ctgov-nct02693691-2022-04-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02693691-2022-04-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: CardioMEMS European Monitoring Study for Heart Failure
- Acronym: MEMS-HF
- Condition: Heart Failure
- Intervention (Device): CardioMEMS HF System
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry intervention name matches this record: CardioMEMS HF System (`cardio:cardiomems-hf-system`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: 47b1b3c571d73b05679444aeffba7d146edad362b2fd2639dcc8aeb6407a6289
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
